Connect Biopharma Holdings Limited

Direct answer

Connect Biopharma Holdings Limited is publicly traded on NASDAQ under the ticker CNTB.

Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company dedicated to discovering and advancing immune modulators. Its primary objective is to develop treatments for serious autoimmune diseases and various inflammatory conditions. The company's lead investigational therapy is CBP-201, an anti-interleukin-4 receptor alpha antibody. This candidate is currently in Phase IIb clinical trials,...

Can you invest in Connect Biopharma Holdings Limited?

Yes. Connect Biopharma Holdings Limited is publicly traded on NASDAQ under the ticker CNTB.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Connect Biopharma Holdings Limited

Detailed equity research is provided by MarketSnap.